Quantum-Si

Quantum-Si, Inc. develops a protein sequencing platform of proteomics. It offers single molecule analysis, and democratizing its use by providing researchers and clinicians access to the proteome. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Guilford, CT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Quantum-Si reports mixed Q4 results, eyes growth with Carbon launch

Quantum-Si's Q4 2022 earnings call showcased a mix of financial challenges and operational successes. The company's focus on innovation, product development, and commercialization efforts positions it well for future growth and impact in the healthcare industry.

Quantum-Si reports Q1 revenue growth, plans marketing expansion

Quantum-Si's Q1 2023 performance showed promising revenue and customer orders, but challenges persist with high operating expenses leading to an EBITDA loss. The company's focus on innovation and market expansion presents growth opportunities in the coming quarters.

Quantum-Si faces revenue hurdles in Q2 2023 earnings call

Quantum-Si's Q2 2023 performance showed revenue and gross profit figures, but challenges in meeting expectations led to significant losses. The company's strengths lie in the commercial team's positive feedback and strategic hires, while opportunities exist in realignment and disciplined growth strategies. Addressing revenue challenges, R&D alignment, and customer feedback are key priorities for Quantum-Si.

Quantum-Si (QSI) reports Q3 revenue growth and eyes global expansion

Quantum-Si (QSI) shows promising progress in revenue growth, product innovation, and market interest, despite facing challenges in expenses and profitability.
The company's strategic focus on commercializing key products and expanding internationally presents significant growth opportunities in the coming quarters.
Overall, QSI's financial performance, product roadmap, and market strategies position it for future success, pending effective execution and cost management.

Quantum-Si reports Q4 loss, eyes growth with innovative sequencing

Quantum-Si's Q4 2023 performance reflects a focus on innovation and market expansion despite a net loss, with strong revenue guidance for 2024.
The company's strategic strengths lie in its disruptive technology, product development initiatives, and market positioning in key regions.
Challenges in managing expenses and achieving profitability underscore the need for operational efficiency and competitive differentiation.
Amidst challenges, Quantum-Si has opportunities to drive growth through new product launches, market expansion, and meeting increasing market demand.

Quantum-Si reports revenue growth and strategic priorities for 2024

Quantum-Si's Q2 2024 performance showed revenue growth and improved net loss.
The company's strengths lie in financial reserves, guidance, and strategic priorities.
Challenges include managing expenses and balancing financial strength with innovation.
Opportunities arise from new board additions, technology potential, and market focus.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Quantum-SI released its Q2 2023 earnings report, which showed lower-than-expected revenue and reduced forward guidance. The company shelved its carbon product and identified problems with its AI software. Despite the market's negative reaction, the company has strong potential in the protein sequencing market and has a solid financial position.

Quantum-Si: Market Overreaction May Provide An Excellent Entry Point

Quantum-Si stock beat on earnings this morning, but suffered a sales miss. Worse than that, sales actually slowed down between Q1 and Q2.

Why Quantum-Si Stock Crashed 35% Today

Quantum-Si incorporated (NASDAQ:QSI ) Q2 2023 Earnings Conference Call August 7, 2023 8:30 AM ET Company Participants Juan Avendano - Head, Investor Relations Jeff Hawkins - Chief Executive Officer Jeff Keyes - Chief Financial Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Yuan Zhi - B. Riley Swayampakula Ramakanth - H.C.

Quantum-Si incorporated (QSI) Q2 2023 Earnings Call Transcript

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2023 Financial Results.

Quantum-Si Reports Second Quarter 2023 Financial Results

Applied DNA Sciences

Broadwind Energy

Investors tend to have a love-hate relationship with penny stocks. On the one hand, they offer the possibility of fascinating returns, due to the underlying stock's volatility, and the ability to purchase large shares with relatively little capital.

3 Penny Stocks to Buy Before the Breakout

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference.

Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference

The medical-equipment maker specializes in equipment for the large-scale studying of proteins. The company went public in 2021.

Why Shares of Quantum-Si Jumped This Week

One of Cathie Wood's ETFs has been buying startup Quantum-Si again. This company has promising technology, but it generates no meaningful revenue yet.

Is Cathie Wood Stock Quantum-Si a Buy?

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023.

Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023

A recent disclosure shows that Ark Invest has made another substantial investment in Quantum-Si. The young biotech has developed a semiconductor-based protein sequencing platform.

Does Cathie Wood Have Her Hands on the Next Big Semiconductor Stock?

Quantum-Si stock jumped early in Friday's trading on news that Ark Invest had purchased more shares. But investors taking profit on the stock and a reversal for the broader market wiped out the gains.

Why Quantum-Si Stock Was Highly Volatile Today

Cathie Wood's Ark Genomic Revolution ETF has added to its Quantum-Si position. The company said it plans to launch a second protein sequencing product in the second half of this year.

Why Shares of Quantum-Si Are Up Thursday

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations.

Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Debuts New Headquarters in Branford, Connecticut.

Quantum-Si Debuts New Headquarters in Branford, Connecticut

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Jefferies Healthcare Conference.

Quantum-Si to Participate in the Jefferies Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors.

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Scott Mendel Elected to Quantum-Si Board of Directors.

Scott Mendel Elected to Quantum-Si Board of Directors

Quantum-Si's proprietary protein detection platform has begun generating revenue, although it's not expected to significantly affect the cash-burn rate immediately. The company's financial stability extends till 2026 at the current burn rate, but rapid revenue generation and financial discipline are vital for survival post-2025.

Assessing Quantum-Si's Path To Commercialization

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2023 Financial Results.

Quantum-Si Reports First Quarter 2023 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si today announced the appointment of Jeff Keyes as its new Chief Financial Officer.

Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer

GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si bolsters executive leadership team with four key appointments.

Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.

Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023

GUILFORD, Conn.--(BUSINESS WIRE)-- #theproteinsequencingcompany--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will be presenting a poster on a new method for detection of arginine post-translational modifications (PTMs) using Platinum™, the world's first next-generation single-molecule protein sequencing platform, at the American Association for Cancer Research's (AACR) Annual Meeting 2023.

Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023

Quantum-Si incorporated (NASDAQ:QSI ) Q4 2022 Results Conference Call March 6, 2023 8:30 AM ET Company Participants Juan Avendano - Head, Investor Relations Jeff Hawkins - Chief Executive Officer Patrick Schneider - President and Chief Operating Officer Claudia Drayton - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Genuity Yuan Zhi - B. Riley Operator Ladies and gentlemen, thank you for standing by.

News for Quantum-Si Stock (QSI)